Geoff Noller – Ibogaine Treatment for Opioid Dependence in New Zealand

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">



Geoff Noller – Ibogaine Treatment for Opioid Dependence in New Zealand: A 12-month Post-treatment Follow-up Observational Study
(Kicking Against the Pricks – Ibogaine Therapy in Aotearoa)

About: This presentation reports on outcomes from a 12-month, post-treatment observational study of opioid dependent subjects, who have received ibogaine therapy. Outcome measures include the Addictions Severity Index (ASI) and the Beck Depression Inventory (BDI-II). The background to ibogaine treatment in New Zealand ...

Continue Reading →

Ibogaine and 5-MeO-DMT – Christopher Ryan, PHD discusses with Crossroads Ibogaine

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">



Crossroad’s own Martin Polanco and Maria Teresa talk on Christopher Ryan, PhD’s podcast talking about Crossroads Ibogaine treatment and 5-MeO-DMT.

Ibogaine is not a scheduled drug in Mexico which allows us to treat patients with Ibogaine. DMT falls under this same category. Ibogaine works in the brain to help eliminate withdrawals in addicts. This is what make Ibogaine such an effective treatment for addiction.

We follow up our ...

Continue Reading →
Page 30 of 37 «...10202829303132...»
UA-77446339-1